Content about treatment of cancer

October 6, 2011

Genomics has the potential to revolutionize the treatment of cancer and the drug industry, and the New York Pharma Forum is sponsoring a symposium on the subject in December.

NEW YORK — Genomics has the potential to revolutionize the treatment of cancer and the drug industry, and the New York Pharma Forum is sponsoring a symposium on the subject in December.

The symposium, titled "The Genomics Revolution: Cancer and Beyond," will feature a panel discussion with executives from drug makes like Bristol-Myers Squibb and Daiichi Sankyo, as well as experts from the Yale Cancer Center and PricewaterhouseCoopers.